Identification of Potent Leukocyte Common Antigen-Related Phosphatase Inhibitors via Structure-Based Virtual Screening 


Vol. 34,  No. 7, pp. 2006-2010, Jul.  2013
10.5012/bkcs.2013.34.7.2006


PDF
  Tumbnail

  Abstract

Leukocyte common antigen-related phosphatase (LAR) has been considered a promising target for the development of therapeutics for neurological diseases. Here, we report the first example for a successful application of the structure-based virtual screening to identify the novel small-molecule LAR inhibitors. Five of these inhibitors revealed micromolar inhibitory activities with the associated IC50 values ranging from 2 to 6 μM. Because the newly identified inhibitors were also screened for having desirable physicochemical properties as a drug candidate, they may serve as a starting point of the structure-activity relationship study to optimize the medical efficacy. Structural features relevant to the stabilization of the new inhibitors in the active site of LAR are discussed in detail.

  Statistics
Cumulative Counts from November, 2022
Multiple requests among the same browser session are counted as one view. If you mouse over a chart, the values of data points will be shown.


  Cite this article

[IEEE Style]

H. Park, P. N. Chien, H. Chun, S. E. Ryu, "Identification of Potent Leukocyte Common Antigen-Related Phosphatase Inhibitors via Structure-Based Virtual Screening," Bulletin of the Korean Chemical Society, vol. 34, no. 7, pp. 2006-2010, 2013. DOI: 10.5012/bkcs.2013.34.7.2006.

[ACM Style]

Hwangseo Park, Pham Ngoc Chien, Ha-Jung Chun, and Seong Eon Ryu. 2013. Identification of Potent Leukocyte Common Antigen-Related Phosphatase Inhibitors via Structure-Based Virtual Screening. Bulletin of the Korean Chemical Society, 34, 7, (2013), 2006-2010. DOI: 10.5012/bkcs.2013.34.7.2006.